Carlisle Steady Amid Peers as Q3 Print Approaches
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
CSL gained 4.7% over the past week to $345.97, roughly in line with the median move across its closest peers: TREX led the group with a 10.2% weekly advance, JBI added 6.5%, and LPX rose 5.3%, while CSW and SGO gained 2.6% and 0.6% respectively. CSL sits toward the middle of the peer pack, neither the standout nor the laggard.
Short interest at Carlisle is modest relative to the group but has been building. It now runs at 4.7% of the free float, up about 14% over the past month. Most of that increase came in a step-change around late September rather than a steady grind higher, and the position has been broadly flat since mid-October. The borrow market places no real constraint on bears: availability remains around 1,328%, meaning lendable shares outnumber the existing short position by more than thirteen to one, and cost to borrow is 0.40%, which has eased roughly 9% over the past week. Options positioning stays firmly call-skewed, with the put/call ratio at 0.19, sitting near the 52-week low and just below its 20-day average. Taken together, the positioning picture is one of limited conviction on either side.
Analyst sentiment is constructive but has been losing altitude since the July print. Baird, which raised its target to $425 after Q2 results, cut it first to $405 in July and then to $402 in mid-October, maintaining its Outperform rating each time. Truist holds a Hold with a $340 target, just below where the stock trades today. The consensus mean of $398.25 implies around 15% upside from current levels, but that gap has been compressing as targets drift lower. The debate centres on Carlisle's two main divisions: bulls point to CWT's acquisition-driven growth and an eventual recovery in non-residential construction; bears flag the CCM segment's volume headwind from weaker new-build activity and the EBITDA miss that accompanied the prior quarter. The forward earnings picture has been revised sharply upward, with the 12-month forward EPS growth factor ranking in the 92nd percentile, but the quality of that revision will be what analysts examine most closely in tomorrow's release.
The one clear reference point in the near-term history: after the July Q2 print, the stock gained 6.4% on the day and extended to 10.8% over the following week. The October print will test whether the CCM segment's volume trajectory has stabilised enough to justify a similar response, and whether the gap between the current price and the analyst consensus can begin to close again.
Stocks in this article
See the live data behind this article on ORTEX.
Open CSL on ORTEX →How this article was generated
- Generated
- 27 Oct 2026, 04:05
- Data as of
- 27 Oct 2026, 04:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.